SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: I. Luttichuys who wrote (573)4/7/1997 11:59:00 PM
From: Matthew Wecksell   of 1762
 
Okay Bennett - here's The Rules:

Any brokerage worth its license will NOT let the sales people so much as talk to the analysts. I ran this buy a friend just after he started working at Lazar Freres. Basically, if they (sales) knows what the analyst will do in advance and they make a market in the security just prior to the coverage, then they'd make a bundle on the rise in volume (MMs get the difference between the bid and sell.) If they just buy knowing that a "strong buy" recommendation will send the price even higher, that's insider trading. Unless companies want to royally piss off the SEC, they keep a big Chineese wall between Sales and Research.

Heck, an IT consultancy (The Gartner Group) owns Soundview, and even when both companies were small, Soundview was kept in another building. (The IT analysts have NDA over all sorts of info that brokers *can't* have.)

NO ONE breaks the Chineese wall. They can make educated guesses (like you have about what Eric Hect will *problably* do, but it's not the same.)

Signing off and back to the med texts...
Matthew B. Wecksell
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext